Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Long Term Follow-up Observational Study of Patients Treated With Inaticabtagene Autoleucel Injection

NCT06461351 is registered in ClinicalTrials.gov with Juventas Cell Therapy Ltd. as lead sponsor.

NCT NCT06461351
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06461351 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Long Term Follow-up Observational Study of Patients Treated With Inaticabtagene Autoleucel Injection
Lead sponsor
Juventas Cell Therapy Ltd.
Phase
Observational
Overall status
Recruiting
Start date
March 30, 2024
Completion date
March 30, 2040
Enrollment
1,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

b-cell tumors